| Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005) |
|---|
| 01/30/2003 | WO2003008371A1 Substituted 4-aminocyclohexanol derivatives |
| 01/30/2003 | WO2003007990A1 Myosin agonist |
| 01/30/2003 | WO2003007954A2 Sulfonyl aryl hydroxamates and their use as matrix metalloprotease inhibitors |
| 01/30/2003 | WO2003007930A2 Use of sulfonyl aryl or heteroaryl hydroxamic acids and derivatives thereof as aggrecanase inhibitors |
| 01/30/2003 | WO2002096874A3 Method for producing biperiden iv |
| 01/30/2003 | WO2002047679A8 Nonpeptide agonists and antagonists of vasopressin receptors |
| 01/30/2003 | US20030022893 Hydroxamic and carboxylic acid derivatives |
| 01/30/2003 | US20030022891 Melanin-concentrating hormone (MCH); treating metabolic and eating disorders, such as hyperphagia, and diabetes; urea, thiourea and cyano-guanidine compounds of given formula |
| 01/30/2003 | US20030021773 Arginine mimetics as factor Xa inhibitors |
| 01/30/2003 | CA2453613A1 Sulfonyl aryl hydroxamates and their use as matrix metalloprotease inhibitors |
| 01/30/2003 | CA2453602A1 Use of sulfonyl aryl or heteroaryl hydroxamic acids and derivatives thereof as aggrecanase inhibitors |
| 01/29/2003 | EP1279519A2 Image forming material and ammonium compound |
| 01/29/2003 | EP1278784A2 Catalysts containing n-pyrrolyl substituted nitrogen donors |
| 01/29/2003 | EP1278758A1 Combretastatin a-1 phosphate and combretastatin b-1 phosphate prodrugs |
| 01/29/2003 | EP1278740A1 Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain |
| 01/29/2003 | EP1278736A1 Quaternary salts of n-substituted cyclic or acyclic amines as pharmaceuticals |
| 01/29/2003 | EP1278731A1 Cyclic quaternary ammonium compounds |
| 01/29/2003 | EP1278719A1 Naphthamide neurokinin antagonists for use as medicaments |
| 01/29/2003 | EP1278712A2 Nitroaromatic solubilizer for nitroxyls in aromatic solvents |
| 01/29/2003 | EP1064253B1 Anti-tumour agents |
| 01/29/2003 | EP0888319B1 Substituted 1,2,3,4-tetrahydronaphthalene derivatives |
| 01/29/2003 | EP0817772B1 Pyrrolidinyl hydroxamic acid compounds and their production process |
| 01/29/2003 | CN1394203A Piperidine and piperazine derivatives which function as 5-HT2A receptor antagonists |
| 01/29/2003 | CN1394199A Peptide derivatives and their pharmaceutically acceptable salts, processes for preparation of both, and use thereof |
| 01/29/2003 | CN1100033C Phenylthanolaminotetralin carboxamide derivatives |
| 01/29/2003 | CN1100032C 3,4-disubstituted phenylethanolamino 1,2,3,4-tetralincarboxamide derivatives |
| 01/28/2003 | US6512145 Using metal alcoholate and organometallic compound as catalyst |
| 01/28/2003 | US6512002 Methods of treatment for premature ejaculation in a male |
| 01/28/2003 | US6511991 Nitric oxide-releasing amidine- and enamine-derived diazeniumdiolates, compositions and uses thereof and method of making same |
| 01/28/2003 | US6511980 For therapy of gastrointestinal reflux disorders, eating disorders leading to obesity and irritable bowel disorder |
| 01/28/2003 | US6511979 Methods for treating conditions modulated by lactosylceramide |
| 01/24/2003 | WO2002016308A1 Phenyl- and phenylalkyl-substituted ethanolamines and ethylenediamines |
| 01/23/2003 | WO2003006453A1 Aminediols for the treatment of alzheimer's disease |
| 01/23/2003 | WO2003006444A2 Substituted amides, sulfonamides and ureas useful for inhibiting kinase activity |
| 01/23/2003 | WO2003006427A1 Compounds that release nitric oxide at controlled rates upon photolysis |
| 01/23/2003 | WO2003006423A1 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
| 01/23/2003 | WO2003006422A1 New derivatives of substituted anilines with herbicidal activity |
| 01/23/2003 | WO2002098367A3 Hybrid 2-aminotetralin and aryl-substituted piperazine compounds and their use in altering cns activity |
| 01/23/2003 | WO2001070669A3 Process for forming an amide bond |
| 01/23/2003 | US20030018195 Alpha-aminoacetic acid derivatives- alpha4beta7 receptor antagonists |
| 01/23/2003 | US20030018190 Valency platform molecules comprising carbamate linkages |
| 01/23/2003 | US20030018062 Deacetylase inhibitors |
| 01/23/2003 | US20030018059 Antiinflammatory agents; antihistamines; antiallergens |
| 01/23/2003 | US20030018034 Piperazine compounds and medicinal use thereof |
| 01/23/2003 | CA2453503A1 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
| 01/23/2003 | CA2453451A1 Aminediols for the treatment of alzheimer's disease |
| 01/23/2003 | CA2453169A1 Substituted amides, sulfonamides and ureas useful for inhibiting kinase activity |
| 01/22/2003 | EP1277771A2 Living polymerisation process for the production of sequenced polymers using functional radical initiators |
| 01/22/2003 | EP1277746A2 N-benzylpiperazine derivatives, process for their preparation and pharmaceutical compositions thereof |
| 01/22/2003 | EP1277729A1 Ppar (gamma) modulators |
| 01/22/2003 | EP1276732A1 Amides of r-2-(aminoaryl)-propionic acids for use in theprevention of leucocyte activation" |
| 01/22/2003 | EP1276731A2 Branched adamantyl and noradamantyl aryl- and aralkylpiperazines with serotonin 5-ht 1a activity |
| 01/22/2003 | EP1276718A2 Small technetium-99m and rhenium labeled agents and methods for imaging tumors |
| 01/22/2003 | EP1071660B1 N-sulphonyl and n-sulphinyl phenylglycinamide |
| 01/22/2003 | CN1392137A New cyclic alpha-amino-gamma hydroxy amide compound, its preparing method and medicinal composition containing said compound |
| 01/22/2003 | CN1099406C Alkoxy acetic acid derivatives |
| 01/21/2003 | US6509463 Isocyanoalkylcarbonic acid derivatives, the reaction thereof in isocyanide multicomponent reactions to form sec-amido-alkylcarbonic acid derivatives, and those sec-amidoalkyl-carbonic acid derivatives |
| 01/21/2003 | US6509356 1-(4-(Substituted alkoxy)benzyl)naphthalene compounds having estrogen inhibitory activity |
| 01/21/2003 | US6509329 Cyclic diamine compound with 6-membered ring groups |
| 01/17/2003 | WO2002006269A1 Cyclic amino acid derivatives |
| 01/17/2003 | CA2415964A1 Cyclic amino acid derivatives |
| 01/16/2003 | WO2003004515A1 Process for production of estradiol derivatives, intermediates used in the process and process for production thereof |
| 01/16/2003 | WO2003004480A2 Substituted piperazine and diazepanes as histamine h3 receptor agonists |
| 01/16/2003 | WO2003004472A1 Arylamines for the treatment of conditions associated with gsk-3 |
| 01/16/2003 | WO2003004471A1 Multifunctional alkoxyamines based on polyalkylpiperidines, polyalkylpiperazinones and polyalkylmorpholinones and their use as polymerization regulators/initiators |
| 01/16/2003 | WO2002070467B1 Derivatives of diphenylurea, diphenyloxalic acid diamide and diphenylsulfuric acid diamide and their use as medicaments |
| 01/16/2003 | WO2002046129A3 Inhibitors of histone deacetylase |
| 01/16/2003 | US20030013881 Such as 4-((6-(3,5-difluoro-phenyl)-5-(S)-(3-dipropylcarb-amoyl-benzoyl-amino)-2-(R)-ethyl-4-(S)-hydroxy-hexanoylamino)-methyl)-cyclohexanecarboxylic acid for inhibiting secretase activity and cleavage of amyloid precursor protein |
| 01/16/2003 | US20030013847 Pyruvate derivatives |
| 01/16/2003 | US20030013846 Cytoprotective agents |
| 01/16/2003 | US20030013772 Composition, synthesis and therapeutic applications of polyamines |
| 01/16/2003 | US20030013760 Substituted 1-naphthoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 01/16/2003 | US20030013757 Aromatic dicarboxylic acid derivatives |
| 01/16/2003 | US20030013751 Viricides; enzyme inhibitors |
| 01/16/2003 | US20030013725 Amino acid derivatives |
| 01/16/2003 | US20030013723 Novel urokinase inhibitors |
| 01/16/2003 | US20030013722 Piperazinyl-isatins |
| 01/16/2003 | US20030013721 Antiinflammatory agents; immunology; cardiovascular disorders; rheumatic disorders |
| 01/16/2003 | US20030013677 Anticancer agents |
| 01/16/2003 | US20030013657 Reducing oxidation stresses; central nervous system disorders; antiinflammatory agents |
| 01/16/2003 | US20030013656 Reducing oxidation stresses; central nervous system disorders; antiinflammatory agents |
| 01/16/2003 | US20030010256 Compounds for forming alumina films using chemical vapor deposition method and process for preparing the compound |
| 01/16/2003 | CA2452686A1 Arylamines for the treatment of conditions associated with gsk-3 |
| 01/16/2003 | CA2450232A1 Multifunctional alkoxyamines based on polyalkylpiperidines, polyalkylpiperazinones and polyalkylmorpholinones and their use as polymerization regulators/initiators |
| 01/16/2003 | CA2394010A1 Novel n-benzylpiperazine derivatives, their preparation and pharmaceutical compositions containing them |
| 01/15/2003 | EP1275641A2 Benzenesulfonamide derivatives, process for their preparation and pharmaceutical compositions containing them |
| 01/15/2003 | EP1274701A1 Chemical compounds |
| 01/15/2003 | EP1274697A1 Arylpiperazines and their use as metalloproteinase inhibiting agents (mmp) |
| 01/15/2003 | EP1274679A1 Bifunctional inhibitors of malarial proteases and uses thereof |
| 01/15/2003 | EP1274676A2 Polycyclic aryl and heteroaryl substituted 1,4-quinones useful for selective inhibition of the coagulation cascade |
| 01/15/2003 | EP1274457A2 Method and compositions for the treatment of allergic conditions using pgd2 receptor antagonists |
| 01/15/2003 | EP0790989B1 Certain substituted benzylamine derivatives; a new class of neuropeptide y1 specific ligands |
| 01/15/2003 | EP0729468B1 Non-peptide tachykinin receptor antagonists |
| 01/15/2003 | EP0713483B1 Amidine derivatives with nitric oxide synthetase activities |
| 01/15/2003 | CN1391565A Benzophenones as inhibitors of reverse transcriptase |
| 01/15/2003 | CN1391473A VLA-4 inhibitor compounds |
| 01/15/2003 | CN1391469A Npyy5拮抗剂 Npyy5 antagonist |
| 01/15/2003 | CN1098849C 噻唑衍生物 Thiazole derivatives |
| 01/15/2003 | CN1098838C Substituted N-(indole-2-carbonyl)-beta-alanimamides and derivatives as antidiabetic agents |
| 01/14/2003 | US6506939 Producing N-substituted acrylamides and tertiary amines |